167 related articles for article (PubMed ID: 8604659)
1. Use of the intramuscular relative-dose-response test to predict bronchopulmonary dysplasia in premature infants.
Zachman RD; Samuels DP; Brand JM; Winston JF; Pi JT
Am J Clin Nutr; 1996 Jan; 63(1):123-9. PubMed ID: 8604659
[TBL] [Abstract][Full Text] [Related]
2. Plasma retinol-binding protein response to vitamin A administration in infants susceptible to bronchopulmonary dysplasia.
Shenai JP; Rush MG; Stahlman MT; Chytil F
J Pediatr; 1990 Apr; 116(4):607-14. PubMed ID: 2108233
[TBL] [Abstract][Full Text] [Related]
3. Vitamin A status and postnatal dexamethasone treatment in bronchopulmonary dysplasia.
Shenai JP; Mellen BG; Chytil F
Pediatrics; 2000 Sep; 106(3):547-53. PubMed ID: 10969101
[TBL] [Abstract][Full Text] [Related]
4. The relative dose response test based on retinol-binding protein 4 is not suitable to assess vitamin A status in very low birth weight infants.
Schmiedchen B; Longardt AC; Bührer C; Raila J; Loui A; Schweigert FJ
Neonatology; 2014; 105(2):155-60. PubMed ID: 24356375
[TBL] [Abstract][Full Text] [Related]
5. Vitamin A status after prophylactic intramuscular vitamin A supplementation in extremely low birth weight infants.
Chabra S; Mayock DE; Zerzan J; Bittner R; Neufeld MD; Gleason CA
Nutr Clin Pract; 2013 Jun; 28(3):381-6. PubMed ID: 23462416
[TBL] [Abstract][Full Text] [Related]
6. A comparison of three vitamin A dosing regimens in extremely-low-birth-weight infants.
Ambalavanan N; Wu TJ; Tyson JE; Kennedy KA; Roane C; Carlo WA
J Pediatr; 2003 Jun; 142(6):656-61. PubMed ID: 12838194
[TBL] [Abstract][Full Text] [Related]
7. Effect of vitamin A supplementation of intravenous lipids on early vitamin A intake and status of premature infants.
Werkman SH; Peeples JM; Cooke RJ; Tolley EA; Carlson SE
Am J Clin Nutr; 1994 Mar; 59(3):586-92. PubMed ID: 8116534
[TBL] [Abstract][Full Text] [Related]
8. Sequential evaluation of plasma retinol-binding protein response to vitamin A administration in very-low-birth-weight neonates.
Shenai JP; Rush MG; Parker RA; Chytil F
Biochem Mol Med; 1995 Feb; 54(1):67-74. PubMed ID: 7551819
[TBL] [Abstract][Full Text] [Related]
9. Intramuscular relative dose response (RDR) determination of liver vitamin A stores in rats.
Zachman RD; Chen XM
J Nutr; 1991 Feb; 121(2):187-91. PubMed ID: 1825326
[TBL] [Abstract][Full Text] [Related]
10. Low plasma retinol concentrations increase the risk of developing bronchopulmonary dysplasia and long-term respiratory disability in very-low-birth-weight infants.
Spears K; Cheney C; Zerzan J
Am J Clin Nutr; 2004 Dec; 80(6):1589-94. PubMed ID: 15585773
[TBL] [Abstract][Full Text] [Related]
11. Soluble E-selectin, soluble L-selectin and soluble ICAM-1 in bronchopulmonary dysplasia, and changes with dexamethasone.
Ballabh P; Kumari J; Krauss AN; Shin JJ; Jain A; Auld PA; Lesser ML; Cunningham-Rundles S
Pediatrics; 2003 Mar; 111(3):461-8. PubMed ID: 12612222
[TBL] [Abstract][Full Text] [Related]
12. Comparison of enteral and intramuscular vitamin A supplementation in preterm infants.
Landman J; Sive A; Heese HD; Van der Elst C; Sacks R
Early Hum Dev; 1992 Sep; 30(2):163-70. PubMed ID: 1493768
[TBL] [Abstract][Full Text] [Related]
13. Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia.
Shenai JP; Kennedy KA; Chytil F; Stahlman MT
J Pediatr; 1987 Aug; 111(2):269-77. PubMed ID: 3302193
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the modified relative dose response (MRDR) and the relative dose response (RDR) in the assessment of vitamin A status in malnourished children.
Wahed MA; Alvarez JO; Khaled MA; Mahalanabis D; Rahman MM; Habte D
Am J Clin Nutr; 1995 Jun; 61(6):1253-6. PubMed ID: 7762526
[TBL] [Abstract][Full Text] [Related]
15. Effect of postnatal steroid administration on serum vitamin A concentrations in newborn infants with respiratory compromise.
Georgieff MK; Mammel MC; Mills MM; Gunter EW; Johnson DE; Thompson TR
J Pediatr; 1989 Feb; 114(2):301-4. PubMed ID: 2915291
[No Abstract] [Full Text] [Related]
16. Vitamin A Supplementation for Prevention of Bronchopulmonary Dysplasia: Cornerstone of Care or Futile Therapy?
Gawronski CA; Gawronski KM
Ann Pharmacother; 2016 Aug; 50(8):680-4. PubMed ID: 27147702
[TBL] [Abstract][Full Text] [Related]
17. Vitamin A supplementation for prevention of bronchopulmonary dysplasia in very-low-birth-weight premature Thai infants: a randomized trial.
Kiatchoosakun P; Jirapradittha J; Panthongviriyakul MC; Khampitak T; Yongvanit P; Boonsiri P
J Med Assoc Thai; 2014 Oct; 97 Suppl 10():S82-8. PubMed ID: 25816542
[TBL] [Abstract][Full Text] [Related]
18. Vitamin A status of neonates with bronchopulmonary dysplasia.
Shenai JP; Chytil F; Stahlman MT
Pediatr Res; 1985 Feb; 19(2):185-8. PubMed ID: 3982875
[TBL] [Abstract][Full Text] [Related]
19. Cord blood fibroblast growth factor-10 as a possible predictor of bronchopulmonary dysplasia in preterm infants.
Mohamed WA; Aseeri MA
J Neonatal Perinatal Med; 2014 Jan; 7(2):101-5. PubMed ID: 25104125
[TBL] [Abstract][Full Text] [Related]
20. Early postnatal additional high-dose oral vitamin A supplementation versus placebo for 28 days for preventing bronchopulmonary dysplasia or death in extremely low birth weight infants.
Meyer S; Gortner L;
Neonatology; 2014; 105(3):182-8. PubMed ID: 24434948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
